期刊文献+

质子泵抑制剂致急性间质性肾炎的临床及病理特征分析 被引量:10

下载PDF
导出
摘要 目的探讨质子泵抑制剂(PPI)所致的急性间质性肾炎(AIN)的临床及病理特征。方法分析12例PPI致AIN患者的临床表现、实验室检查、病理特征及治疗和预后情况。结果 PPI致AIN患者临床表现以发热(66.7%)、腰痛(75.0%)、少尿(50.0%)为主。实验室检查发现肌酐、尿素、尿酸升高,肌酐清除率降低,尿蛋白或潜血阳性,尿液N-乙酰-β-D氨基葡萄糖苷酶、尿α1微球蛋白、尿视黄醇蛋白升高。PPI致AIN患者主要病理学表现包括肾小管上皮细胞变性(66.7%)、肾间质水肿(66.7%)、肾间质弥漫性细胞浸润(58.3%)。经糖皮质激素治疗后10例治愈。结论 PPI致AIN患者临床表现不典型,可出现肾功能及尿检异常,病理表现以肾间质小管损伤为主。
出处 《重庆医学》 CAS 北大核心 2015年第23期3271-3272,共2页 Chongqing medicine
  • 相关文献

参考文献14

  • 1Cippa PE, Fehr T, Gaspert A, et al. Drug-induced acute interstitial nephritis [J]. Praxis (Bern 1994), 2014, 103 (15) :865-872.
  • 2Chen D, Luo C, Tang Z, et al. Delayed renal function re- covery from drug-induced acute interstitial nephritis[J]. Am J Med Sci,2012,343(1) :36-39.
  • 3Perazella MA, Markowitz GS. Drug-induced acute inter- stitial nephritis[J]. Nat Rev Nephrol, 2010, 6 (8) : 461- 470.
  • 4丁小强,傅辰生.药物所致急性间质性肾炎[J].中华肾脏病杂志,2005,21(3):123-124. 被引量:31
  • 5Sierra F, Suarez M, Rey M, et al. Systematic review:pro-ton pump inhibitor-associated acute interstitial nephritis [J]. Aliment Pharmacol Ther,2007,26(4) : 545-553.
  • 6裴振峨.奥美拉唑致急性间质性肾炎[J].临床药物治疗杂志,2007,5(3):58-60. 被引量:12
  • 7Berney-Meyer L, Hung N, Slatter T, et al. Omeprazole-in- duced acute interstitial nephritis: a possible Th1-Th17- mediated injury? [J]. Nephrology (Carlton), 2014, 19 (6) :359-365.
  • 8Klassen S, Krepinsky JC, Prebtani AP. Pantoprazole-in- duced acute interstitial nephritis [J]. CMAJ, 2013, 185 (1) : 56-59.
  • 9Yildirim T,Yilmaz R, Baydar DE, et al. Lansoprazole-in- duced acute allergic interstitial nephritis in a renal trans- plant recipient:a case report[J]. Int Urol Nephrol, 2012, 44(6) : 1903-1906.
  • 10Geevasinga N, Kairaitis L, Rangan GK,et al. Acute inter- stitial nephritis secondary to esomeprazole [J]. Med J Aust, 2005,182(5) : 235-236.

二级参考文献50

  • 1张晓东,方敬爱,武明虎.奥美拉唑导致间质性肾炎的临床分析[J].中国中西医结合肾病杂志,2006,7(9):543-543. 被引量:19
  • 2程骏章,姜鸿.奥美拉唑致过敏性紫癜性肾炎1例[J].中国药师,2007,10(5):477-477. 被引量:9
  • 3[1]Walsh JH,Peterson WL.The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.N Engl J Med,1995,333:984-991
  • 4[2]Vigneri S,Termini R,Leandro G,et al.A comparison of five maintenance therapies for reflux esophagitis.N Engl J Med,1995,333:1106-1110
  • 5[3]Hawkey C,J,Karraxch JA,Sczepanaki L,et al.Omeprazole compared with misoprostol for ulcers associated with onsteroidal antiinflammatory drugs.N Engl J Med,1998,338:727-734
  • 6[4]Kodner CM,Kudrimoti A.Diagnosis and management of acute interstitial nephritis.Am Fam Physician,2003,67 (12):2527-2534
  • 7[5]Solvell L.The clinical safety of omeprazole.Digestion,1990,47(Suppl):59-63
  • 8[6]Jochem V,Kirkpatrick R,Greenson J,et al.Fulminant hepatic failure related to omeprazole.Am J Gastroenterol,1992; 87:523-524
  • 9[7]Vera Rivera M,Pou Potau M,Botey Puig A.Omerprazole-induced interstitial nephritis:a reversible cause of acute renal failure.Med Clin (Barc),2002,118 (1):39
  • 10[8]SzalatA,Krasilnikov I,Bloch A,et al.Acute renal failure and interstitial nephritis in a patient treated with rofecoxib:case report and review of the literature.Arthr Rheum,2004,51 (4):670-673

共引文献67

同被引文献52

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部